- Home
- WRBY vs PTGX Comparison
WRBY vs PTGX Comparison
Compare WRBY & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRBY
- PTGX
- Stock Information
- Founded
- WRBY 2010
- PTGX 2006
- Country
- WRBY United States
- PTGX United States
- Employees
- WRBY N/A
- PTGX N/A
- Industry
- WRBY Ophthalmic Goods
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- WRBY Health Care
- PTGX Health Care
- Exchange
- WRBY Nasdaq
- PTGX Nasdaq
- Market Cap
- WRBY 1.9B
- PTGX 2.8B
- IPO Year
- WRBY 2021
- PTGX 2016
- Fundamental
- Price
- WRBY $17.23
- PTGX $47.91
- Analyst Decision
- WRBY Buy
- PTGX Strong Buy
- Analyst Count
- WRBY 8
- PTGX 7
- Target Price
- WRBY $16.88
- PTGX $52.83
- AVG Volume (30 Days)
- WRBY 1.4M
- PTGX 450.1K
- Earning Date
- WRBY 11-07-2024
- PTGX 11-08-2024
- Dividend Yield
- WRBY N/A
- PTGX N/A
- EPS Growth
- WRBY N/A
- PTGX N/A
- EPS
- WRBY N/A
- PTGX 2.75
- Revenue
- WRBY $719,929,000.00
- PTGX $319,120,000.00
- Revenue This Year
- WRBY $15.94
- PTGX $400.33
- Revenue Next Year
- WRBY $13.07
- PTGX N/A
- P/E Ratio
- WRBY N/A
- PTGX $17.54
- Revenue Growth
- WRBY 13.67
- PTGX 125.73
- 52 Week Low
- WRBY $9.83
- PTGX $13.76
- 52 Week High
- WRBY $18.37
- PTGX $48.89
- Technical
- Relative Strength Index (RSI)
- WRBY 57.79
- PTGX 60.40
- Support Level
- WRBY $16.71
- PTGX $45.33
- Resistance Level
- WRBY $17.86
- PTGX $48.89
- Average True Range (ATR)
- WRBY 0.66
- PTGX 1.28
- MACD
- WRBY 0.01
- PTGX 0.11
- Stochastic Oscillator
- WRBY 62.77
- PTGX 77.11
About WRBY Warby Parker Inc.
Warby Parker Inc is engaged in designing and developing designer prescription glasses and contacts, and providing the facility of eye exams and vision tests. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.